Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.15.1 extracted from

  • Coppo, R.; Peruzzi, L.; Amore, A.; Piccoli, A.; Cochat, P.; Stone, R.; Kirschstein, M.; Linne, T.
    IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria (2007), J. Am. Soc. Nephrol., 18, 1880-1888.
    View publication on PubMed

Application

Application Comment Organism
medicine treatment with angiotensin-converting enzyme inhibitors is of benefit in reducing the progression of renal damage in young patients with moderately proteinuric IgA nephropathy Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
benazepril treatment with angiotensin-converting enzyme inhibitors is of benefit in reducing the progression of renal damage in young patients with moderately proteinuric IgA nephropathy Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
children and young people with IgA nephropathy and moderate proteinuria
-